Medical News

RSS

OtoSCOPE method offers single-run genetic testing for hearing loss

Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.

16 Nov 2010

Reducing salt intake can enhance health of young adults in future: Research

Cutting back on salt in teenagers' diets by as little as one-half teaspoon, or three grams, a day, could reduce the number of young adults with high blood pressure by 44 to 63 percent, according to new research presented Sunday, Nov. 14 at the American Heart Association's Scientific Sessions 2010 meeting in Chicago.

16 Nov 2010

Universal Health Services acquires Psychiatric Solutions

Universal Health Services, Inc. announced today that it has completed its previously announced acquisition of Psychiatric Solutions, Inc.

16 Nov 2010

Men treated with hormone-based therapy for prostate cancer face higher risk of colorectal cancer: Study

Men treated with hormone-based therapy for prostate cancer faced a 30 percent to 40 percent higher risk of colorectal cancer, compared to patients who did not receive this treatment, according to a new study.

16 Nov 2010

BiovaxID lymphoma vaccine to be featured at ASH Meeting

Biovest International, Inc. today announced that BiovaxID, Biovest's personalized lymphoma vaccine, will be featured in an oral presentation at the American Society of Hematology (ASH) Annual Meeting on Monday, December 6th in Orlando, Florida.

16 Nov 2010

Large tobacco companies fight tougher restrictions around the globe

As sales to developing nations become ever more important to giant tobacco companies, they are stepping up efforts around the world to fight tough restrictions on the marketing of cigarettes.

16 Nov 2010

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

Education for women is the most important factor for positively influencing the health of women and children, Indian President Pratibha Patil said on Saturday at a meeting in New Delhi of The Partnership for Maternal, Newborn & Child Health (PMNCH), IANS/Sify News reports. "Education is a powerful driver of health. The relationship between poverty, lack of education and limited access to health services, is well recognised," Patil said at the start of the two-day conference (11/13).

16 Nov 2010

St. Jude presents results from ASSERT trial for stroke at American Heart Association

St. Jude Medical, Inc., a global medical device company, today announced the results of the ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), a St. Jude Medical sponsored trial conducted by the Population Health Research Institute of McMaster University and Hamilton Health Sciences in Hamilton, Canada.

16 Nov 2010

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.

16 Nov 2010

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk Institute for Biological Studies. The study, published in the online edition of Human Molecular Genetics, sets the stage for further investigations into fisetin's neuroprotective properties in Huntington's and other neurodegenerative conditions.

16 Nov 2010

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).

16 Nov 2010

Review: Mercury likely plays role in development of AD

Mercury likely plays a role in the development of Alzheimer's disease, according to a review of relevant scientific literature published this month in The Journal of Alzheimer's Disease. Dr. Joachim Mutter of Germany, Dr. Richard Deth of the United States, and other esteemed researchers collaborated on the groundbreaking article Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism, which clarifies the need for continuing research to understand the cause of neurological diseases such as Alzheimer's.

16 Nov 2010

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

Senator Dick Lugar on Friday said that poorly secured medical laboratories in East African countries, which host insurgent groups linked to Al Qaeda, are vulnerable to bioterrorism, Agence France-Presse reports.

16 Nov 2010

Report shows spells of poverty may have lifelong health implications for children

Spells of poverty, even if temporary, may have lifelong health implications for children, according to the largest report so far reviewing the recent recession's effects on child well-being.

16 Nov 2010

Research suggests targeting spleen may promote healing of spinal cord injury

The spleen, an organ that helps the body fight infections, might also be a source of the cells that end up doing more harm than good at the site of a spinal cord injury, new research suggests.

16 Nov 2010

Infinity announces Phase 1b/2 clinical trial of IPI-926 in patients with metastatic pancreatic cancer

Infinity Pharmaceuticals, Inc. today announced that enrollment is ongoing locally for a Phase 1b/2 clinical trial of IPI-926, Infinity's oral molecule that inhibits Smoothened, a key component of the Hedgehog pathway, in combination with Gemzar (gemicitabine) in patients with previously untreated, metastatic pancreatic cancer.

16 Nov 2010

New i-phone application provides instant access to HIV drug interactions

The University of Liverpool has launched an i-phone application, HIV iChart,that provides healthcare professionals and HIV patients with instant and easy access to information about drug interactions.

16 Nov 2010

Pawlenty seeks to stop health law as he eyes presidency

Kaiser Health News staff writer Christopher Weaver reports, If there was any doubt that protesting on the new health law was good politics for Republican candidates, it evaporated with the midterm election results.

16 Nov 2010

Medicare cuts looming for doctors; Debt panel's health suggestions questioned

"The scheduled cuts [to doctors' reimbursements from Medicare] -- the result of a failed system set up years ago to control costs -- have raised alarms that real damage to Medicare could result if the lame-duck Congress winds up in a partisan standoff and fails to act by Dec. 1. That's when an initial 23 percent reduction would hit. ... Doctors have muddled through with temporary reprieves for years. ... there's no agreement among lawmakers and the Obama administration on how long a reprieve to grant or whether the cost -- about $1 billion per month -- should be added to the deficit or paid for with spending reductions elsewhere" (Alonso-Zaldivar, 11/13).

16 Nov 2010

Celladon presents data on Phase 2 CUPID clinical trial for advanced heart failure at American Heart Association

Targeted Genetics Corporation announced that its partner, Celladon Corporation, today presented 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrating significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

16 Nov 2010

Medical News

OtoSCOPE method offers single-run genetic testing for hearing loss

Reducing salt intake can enhance health of young adults in future: Research

Universal Health Services acquires Psychiatric Solutions

Men treated with hormone-based therapy for prostate cancer face higher risk of colorectal cancer: Study

BiovaxID lymphoma vaccine to be featured at ASH Meeting

Large tobacco companies fight tougher restrictions around the globe

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

St. Jude presents results from ASSERT trial for stroke at American Heart Association

New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Review: Mercury likely plays role in development of AD

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

Report shows spells of poverty may have lifelong health implications for children

Research suggests targeting spleen may promote healing of spinal cord injury

Infinity announces Phase 1b/2 clinical trial of IPI-926 in patients with metastatic pancreatic cancer

New i-phone application provides instant access to HIV drug interactions

Pawlenty seeks to stop health law as he eyes presidency

Medicare cuts looming for doctors; Debt panel's health suggestions questioned

Celladon presents data on Phase 2 CUPID clinical trial for advanced heart failure at American Heart Association

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News